Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development
- PMID: 30395713
- DOI: 10.1021/acs.jmedchem.8b01455
Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development
Abstract
Protein lysine deacylases comprise three zinc-dependent families and the NAD+-dependent sirtuins Sirt1-7, which contribute to aging-related diseases. Few Sirt6-specific inhibitors are available. Trichostatin A, which belongs to the potent, zinc-chelating hydroxamate inhibitors of zinc-dependent deacylases, was recently found to potently and isoform-specifically inhibit Sirt6. We solved a crystal structure of a Sirt6/ADP-ribose/trichostatin A complex, which reveals nicotinamide pocket and acyl channel as binding site and provides interaction details supporting the development of improved deacylase inhibitors.
Similar articles
-
Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.Arch Biochem Biophys. 2018 Jan 15;638:8-17. doi: 10.1016/j.abb.2017.12.009. Epub 2017 Dec 9. Arch Biochem Biophys. 2018. PMID: 29233643 Free PMC article.
-
Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight.Angew Chem Int Ed Engl. 2017 Nov 20;56(47):14836-14841. doi: 10.1002/anie.201709050. Epub 2017 Nov 2. Angew Chem Int Ed Engl. 2017. PMID: 29044784 Free PMC article.
-
Elucidating the Unconventional Binding Mode of a DNA-Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development.ChemMedChem. 2024 Oct 16;19(20):e202400273. doi: 10.1002/cmdc.202400273. Epub 2024 Aug 19. ChemMedChem. 2024. PMID: 38940296 Free PMC article.
-
Sirtuin activators and inhibitors: Promises, achievements, and challenges.Pharmacol Ther. 2018 Aug;188:140-154. doi: 10.1016/j.pharmthera.2018.03.004. Epub 2018 Mar 22. Pharmacol Ther. 2018. PMID: 29577959 Free PMC article. Review.
-
Inhibitors of NAD+ dependent histone deacetylases (sirtuins).Curr Pharm Des. 2008;14(6):562-73. doi: 10.2174/138161208783885380. Curr Pharm Des. 2008. PMID: 18336301 Review.
Cited by
-
Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives.Sci Rep. 2019 Dec 16;9(1):19176. doi: 10.1038/s41598-019-55654-1. Sci Rep. 2019. PMID: 31844103 Free PMC article.
-
Sirtuins-Novel Regulators of Epigenetic Alterations in Airway Inflammation.Front Genet. 2022 May 10;13:862577. doi: 10.3389/fgene.2022.862577. eCollection 2022. Front Genet. 2022. PMID: 35620467 Free PMC article. Review.
-
SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases.Aging Dis. 2022 Dec 1;13(6):1787-1822. doi: 10.14336/AD.2022.0413. eCollection 2022 Dec 1. Aging Dis. 2022. PMID: 36465178 Free PMC article. Review.
-
Emerging Therapeutic Potential of SIRT6 Modulators.J Med Chem. 2021 Jul 22;64(14):9732-9758. doi: 10.1021/acs.jmedchem.1c00601. Epub 2021 Jul 2. J Med Chem. 2021. PMID: 34213345 Free PMC article. Review.
-
Virtual Screening in the Identification of Sirtuins' Activity Modulators.Molecules. 2022 Sep 1;27(17):5641. doi: 10.3390/molecules27175641. Molecules. 2022. PMID: 36080416 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases